CharlesLEdelsteinMD

Nephrology • Aurora, CO

Professor, Medicine, University of Colorado School of Medicine

Join to view full profile

Dr. Edelstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Edelstein's full profile

Already have an account?

Office
12401 E 17th Ave
Aurora, CO 80045
Phone+1 720-848-0000

Fax+1 720-848-6802

Education & Training

University of Cape Town Faculty of MedicineClass of 1979

Certifications & Licensure

CO State Medical License 1997 - 2025
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients Start of enrollment: 2009 Jan 01
Withdrawn

Publications & Presentations

PubMed

89 citations
Circulating IL-6 mediates lung injury via CXCL1 production after acute kidney injury in mice
Nilesh Ahuja, Ana Andres-Hernando, Christopher Altmann, Rhea Bhargava, Jasna Bacalja
American Journal of Physiology. Renal Physiology. 2012-09-15
360 citations
Urinary interleukin-18 is a marker of human acute tubular necrosis.
Chirag R. Parikh, Alkesh Jani, Vyacheslav Y. Melnikov, Sarah Faubel, Charles L. Edelstein
American Journal of Kidney Diseases. 2004-03-01
228 citations
Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury.
Sara J. Holditch, Carolyn N. Brown, Andrew M. Lombardi, Khoa N. Nguyen, Charles L. Edelstein
International Journal of Molecular Sciences. 2019-06-20

Journal Articles

Milestones in Transplantation Kidney Transplantation Effect of Sirolimus on Native Total Kidney Volume After Transplantation in Patients with Autosomal Dominant Polycy...
C L Edelstein, S Davis, A Wiseman, L Chan, ScienceDirect

Press Mentions

XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)December 8th, 2022
XORTX Announces New Clinical Advisory Board MemberAugust 31st, 2021
XORTX Announces New Clinical Advisory Board MemberAugust 31st, 2021
Join now to see all

Grant Support

Mammalian Target Of Rapamycin (MTOR) Signaling In Polycystic Kidney Disease (PKD)National Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
Caspase-1 Signaling In Ischemic Acute Renal FailureNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
Caspase-1 And IL-18 In Ischemic Acute Renal FailureNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
Role Of Caspases In Ischemic Acute Renal FailureNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2005
Caspases And Apoptosis In AdpkdNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2002